Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Treg
83%
Inflammation
77%
Parkinson's Disease
76%
Amyotrophic Lateral Sclerosis
71%
Alpha-synuclein (α-syn)
70%
Alzheimer's Disease
64%
Neurodegeneration
60%
Inflammatory Response
49%
Parkinson's Disease Model
47%
Suppressive Function
39%
Regulatory T Cells
39%
Peripheral Monocytes
37%
MHC Class II
36%
Interleukin-2
36%
Oxidative Stress
35%
Monocytes
30%
Disease Progression
30%
Microglia
29%
Neuroinflammation
26%
Low-dose interleukin-2
25%
Treg Lymphocytes
25%
Myeloid Cells
25%
Ex Vivo Expansion
24%
Acute Phase Proteins
23%
Transcriptional Signature
23%
Neurodegenerative Diseases
21%
T Cell Proliferation
19%
Disease Severity
16%
Microglial Cells
16%
CX3CR1
16%
Disease Burden
16%
Peripheral Immune Cells
15%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
15%
Oxidized Low-density Lipoprotein (ox-LDL)
15%
Microglial Activation
14%
Alzheimer's Disease Model
14%
Moderate to Severe
13%
Healthy Controls
13%
Immunosuppressive Function
13%
Immune Alterations
12%
Peripheral Inflammation
12%
Trial Registration
12%
Alzheimer's Dementia
12%
Induced Pluripotent Stem Cells (iPSCs)
12%
CCR2
12%
Dopaminergic Neurodegeneration
11%
Metabotropic Glutamate Receptor Subtype 4 (mGlu4)
11%
Peripheral Disease
11%
Positive Allosteric Modulator
11%
Biologically Active
11%
Medicine and Dentistry
Parkinson's Disease
60%
Alzheimer's Disease
49%
Ex Vivo
47%
Microglia
42%
Regulatory T Cell
39%
Amyotrophic Lateral Sclerosis
38%
Neurodegeneration
37%
In Vitro
37%
Interleukin 2
36%
Serositis
35%
Diseases
33%
Myeloid Cell
29%
Neuroinflammation
26%
Synuclein
23%
Regulatory T Lymphocyte
23%
Disease Exacerbation
20%
Antigen Presentation
18%
T Cell Proliferation
17%
Degenerative Disease
17%
Biological Marker
14%
Alpha Synuclein
14%
Low Drug Dose
13%
Immunosuppressive Drug
13%
Metabotropic Receptor 4
11%
Allosteric Modulator
11%
Fractalkine
11%
Combination Therapy
11%
T-Helper Cell
11%
M2 Macrophages
11%
Abatacept
11%
Glucagon Like Peptide 1
11%
Glucagon-Like Peptide-1 Agonist
11%
Human T Regulatory Cell
11%
Immunomodulation
11%
Neuroprotective Agent
10%
T Cell
9%
Knockout Mouse
8%
Oxidative Stress
8%
Major Histocompatibility Complex
8%
Dopaminergic Neuron
7%
Inflammatory Cytokine
7%
Adaptive Immunity
7%
Anti-Inflammatory Drug
7%
Oxidized Low Density Lipoprotein
7%
Interleukin 6
7%
Phagocytosis
7%
Intranasal Drug Administration
5%
Light Chain
5%
Interleukin 18
5%
4 Hydroxynonenal
5%
Neuroscience
Parkinson's Disease
100%
Amyotrophic Lateral Sclerosis
64%
Neurodegeneration
63%
T Cell
51%
Microglia
44%
Alzheimer's Disease
39%
Oxidative Stress
37%
Alpha-Synuclein
37%
Synuclein
36%
In Vivo
30%
In Vitro
23%
Acute Phase Protein
23%
Major Histocompatibility Complex
21%
Neurodegenerative Disorder
19%
Myeloid
17%
CX3CR1
17%
Cell Proliferation
14%
Lipopolysaccharide Binding Protein
14%
Dopaminergic Neuron
13%
Chemokine Receptor
13%
Central Nervous System
12%
Interleukin 2
12%
Metabotropic Glutamate Receptor 4
11%
MiR-155
11%
Fractalkine
11%
Dopaminergic
11%
Cell Death
11%
CD4
11%
Gamma Chemokine
11%
Positive Allosteric Modulator
11%
Biological Marker
11%
Cytokine
10%
Anti-Inflammatory
9%
Neuroprotective Agent
9%
Substantia Nigra Pars Compacta
8%
Oxidized Low Density Lipoprotein
8%
Neurofilament Light Chain
7%
CD14
7%
Cell Infiltration
7%
Phagocytosis
7%
Chemokine
6%
Immunotherapy
5%
Substantia nigra
5%
Acquired Immunity
5%
Randomized Controlled Trial
5%
Interleukin 6
5%
